Prevalence of Thrombotic or Embolic Lesions
| Experimental Group . | Heart . | Brain . |
|---|---|---|
| BMTI | ||
| +/+ → +/+a (5 mice) | 0% | 0% |
| sph/sph → +/+a (18 mice) | 72% | 44% |
| +/+ → W/Wv (5 mice) | 0% | 0% |
| sph/sph → W/Wv (5 mice) | 80% | 20% |
| BMTII | ||
| +/+ → +/+a (4 mice) | 0% | 0% |
| sph/sph → +/+a(18 mice) | 89% | 17% |
| +/+ → W/Wv (5 mice) | 0% | 0% |
| sph/sph → W/Wv (5 mice) | 60% | 0% |
| Totals | ||
| +/+ marrow recipients | 0% | 0% |
| sph/sph marrow recipients | 78% | 26% |
| Experimental Group . | Heart . | Brain . |
|---|---|---|
| BMTI | ||
| +/+ → +/+a (5 mice) | 0% | 0% |
| sph/sph → +/+a (18 mice) | 72% | 44% |
| +/+ → W/Wv (5 mice) | 0% | 0% |
| sph/sph → W/Wv (5 mice) | 80% | 20% |
| BMTII | ||
| +/+ → +/+a (4 mice) | 0% | 0% |
| sph/sph → +/+a(18 mice) | 89% | 17% |
| +/+ → W/Wv (5 mice) | 0% | 0% |
| sph/sph → W/Wv (5 mice) | 60% | 0% |
| Totals | ||
| +/+ marrow recipients | 0% | 0% |
| sph/sph marrow recipients | 78% | 26% |
Prevalence as defined in Materials and Methods.